# Coya Therapeutics, Inc. (COYA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/COYA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 494.9K | $ -13.85M | $ -13.68B | $ 0 | $ 43.28B |
| 2025 | $ 8.14M | $ -21.73M | $ -11.00M | $ 0 | $ 43.03M |
| 2024 | $ 3.74M | $ -15.64M | $ -10.81M | $ 0 | $ 39.58M |
| 2023 | $ 6.49M | $ -8.64M | $ -12.10M | $ 0 | $ 35.64M |
| 2022 | $ 0 | $ -13.68M | $ -8.09M | $ 12.97M | $ -8.39M |
| 2021 | $ 0 | $ -5.81M | $ -4.80M | $ 0 | $ 3.64M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 13.40 |

## Other views

- [Metrics](https://sponda.capital/en/COYA.md)
- [Charts](https://sponda.capital/en/COYA/charts.md)
- [Compare](https://sponda.capital/en/COYA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.